Document is current

Any future updates will be listed below

The Current Status of Sakigake Designation in Japan, PRIME in the European Union, and Breakthrough Therapy Designation in the United States

Crossref DOI link: https://doi.org/10.1177/2168479016662682

Published Online: 2017-12-31

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark